
    
      This is a prospective cohort study among adult patients requiring warfarin therapy. Patients
      presenting for anticoagulation will be identified at the start of therapy and followed
      throughout their course until they reach maintenance dose. We will then develop a dosing
      equation for warfarin using patient, environmental and genetic factors.
    
  